Literature DB >> 2993927

Studies on the effects of felodipine on the vascular resistance and reactivity in pentobarbital anesthetized dogs.

B S Jandhyala.   

Abstract

Bilateral perfused hindlimb preparations in pentobarbital anesthetized dogs were utilized in the present study to evaluate vasodilator effects of felodipine, in the presence and in the absence of sympathetic neurogenic tone. Vascular resistance was evaluated by establishing pressure-flow characteristics. A lower dose of this agent (0.01 mumol/kg i.v.) produced significant reductions in the systemic arterial blood pressure and vascular resistance only in the innervated but not in the denervated limb. This effect was shown to be due to interference with noradrenaline induced vasoconstriction. However, a tenfold higher dose of felodipine (0.1 mumol/kg i.v.) was indeed effective in attenuating resistance in the denervated vascular bed; this ability of the higher dose (0.1 mumol/kg) to inhibit vascular resistance may be due to an additional intracellular action of this drug affecting myogenic tone and/or due to inhibition of the vascular effects of the endogenous renin-angiotensin system. In the present experimental model, felodipine, a dihydropyridine calcium antagonist, was equally effective in inhibiting either alpha 1- or alpha 2-mediated vasoconstriction. These data suggest that the ability of felodipine to interfere with sympathetic vasoconstrictor mechanisms primarily contributes to its hypotensive effects in the barbiturate-anesthetized dogs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993927     DOI: 10.1007/bf00496375

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  A comparison of pre- and postsynaptic alpha-adrenergic effects of phenylephrine and tramazoline on blood vessels of the rabbit in vivo.

Authors:  A Steppeler; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

2.  Effects of prolonged hydrochlorothiazide administration on neurogenic tone in the hind limb vasculature.

Authors:  B S Jandhyala; I Cavero; J P Buckley
Journal:  Eur J Pharmacol       Date:  1972-03       Impact factor: 4.432

3.  Attenuation of sympathetic vasoconstriction by nifedipine: the role of vascular alpha 2-adrenoceptors.

Authors:  M Saeed; J Holtz; D Elsner; E Bassenge
Journal:  Eur J Pharmacol       Date:  1983-10-14       Impact factor: 4.432

4.  Interaction of the antihypertensive drug felodipine with calmodulin.

Authors:  S L Bostróm; B Ljung; S Mårdh; S Forsen; E Thulin
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

5.  Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.

Authors:  M F Lokhandwala; S D Kivlighn; B S Jandhyala
Journal:  J Pharmacol Exp Ther       Date:  1984-03       Impact factor: 4.030

Review 6.  Sites of action of Ca2+ channel inhibitors.

Authors:  R A Janis; A Scriabine
Journal:  Biochem Pharmacol       Date:  1983-12-01       Impact factor: 5.858

7.  Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.

Authors:  I Cavero; N Shepperson; F Lefèvre-Borg; S Z Langer
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

8.  Vascular selectivity of felodipine.

Authors:  B Ljung
Journal:  Drugs       Date:  1985       Impact factor: 9.546

9.  Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects.

Authors:  G Johnsson; G Murray; A Tweddel; I Hutton
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha 2-adrenoceptor-mediated vasopressor responses.

Authors:  J C Van Meel; P B Timmermans; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1983-08-19       Impact factor: 4.432

View more
  3 in total

Review 1.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

2.  Renal failure in haemorrhagic shock in dogs: salutary effects of the calcium entry blocker felodipine.

Authors:  M S Chintala; B S Jandhyala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

3.  Restoration of renal and mesenteric hemodynamics by felodipine in a canine model of hemorrhagic shock.

Authors:  M Sabouni; K Hodge; B S Jandhyala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.